Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
dezocin 15 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
antidemensmiddel |
Is a |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Glutamate receptor antagonist |
Is a |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Potassium channel blocker |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
pergolid 1 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
hydrocodonpolistirex 10 mg/5 ml + chlorphenireminpolistirex 8 mg/5 ml oral suspension med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Product containing oxycodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
oxycodonterephthalat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Product containing hydromorphone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid kapsel med modificeret udløsning a 12 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid kapsel med modificeret udløsning a 32 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Product containing ibuprofen and oxycodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Ibuprofen 400 mg and oxycodone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Codeine phosphate 12.5 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Codeine phosphate 12.8 mg and ibuprofen 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
ibuprofen 300 mg + codeinphosphat 20 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Ibuprofen+codeine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Fentanyl 12 microgram/hour prolonged-release transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Product containing phenacemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Psychotropic agent (substance) |
Is a |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
GABA receptor antagonist |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
[X]Benzodiazepines causing adverse effects in therapeutic use |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
[X]Drugs primarily affecting the central nervous system causing adverse effects in therapeutic use |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
overdosis af alkoholafvænningsmiddel |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
overdosis af antabus |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
accidentel overdosis af antabus |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
tilsigtet overdosis af antabus |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
overdosis af antabus, uvist med hvilken hensigt |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Disulfiram 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Acamprosate calcium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Acamprosate calcium 333 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Product containing disulfiram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
accidentel forgiftning med intravenøse anæstetika |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
accidentel forgiftning med CNS-lægemidler |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
1 |
Adverse reaction to central nervous system muscle-tone depressants NOS |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to central nervous system depressants and anesthetics NOS |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Disulfiram 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Disulfiram 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Product containing acamprosate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Psychoactive substance (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Idebenone (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Sodium phenylbutyrate (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Thiethylperazine (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Tetrabenazine |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Thalidomide poisoning |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to other central nervous system depressants and anesthetics |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
allergi over for lægemiddelgrupper med primær effekt på centralnervesystemet |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
1 |
Tafamidis |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
NMDA receptor antagonist |
Is a |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Monoamine oxidase inhibitor |
Is a |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Thiethylperazine malate (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Thiethylperazine maleate |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Tafamidis meglumine (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
accidentel forgiftning med narkotikum |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
2 |
tilsigtet forgiftning med narkotikum |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
2 |
forgiftning med narkotikum, uvist med hvilken hensigt |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
2 |
Forgiftning med opiat OG/ELLER beslægtet narkotikum |
Causative agent |
False |
Central nervous system agent (substance) |
Inferred relationship |
Some |
2 |
Dihydroergocornine mesilate (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Dihydroergocristine mesilate (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Rivastigmine tartrate |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Tacrine hydrochloride |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Tacrine (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Donepezil (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Donepezil hydrochloride (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Galantamine (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Rivastigmine (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Memantine hydrochloride (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Donepezil hydrochloride monohydrate (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|
Parkinsonism caused by dopamine depleting agent (disorder) |
Causative agent |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
1 |
Ifenprodil (substance) |
Is a |
True |
Central nervous system agent (substance) |
Inferred relationship |
Some |
|